Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | SIM0500 |
Synonyms | |
Therapy Description |
SIM0500 is a trispecific antibody targeting GPRC5D and BCMA (TNFRSF17) on tumor cells and CD3 on T-cells, which potentially induces killing of GPRC5D and BCMA (TNFRSF17)-expressing tumor cells and antitumor activity (Blood (2024) 144 (Supplement 1): 3381.2). |